header-lab-new

Baby Genes, Inc. was formed in 2013 to fulfill an unmet need in the Newborn Screening (NBS) and Newborn Diagnostic arena. We are a Clinical Laboratory Improvement Act (CLIA) laboratory using Next Generation Sequencing (NGS) assays focused on reflex/diagnostic testing and supplemental newborn screening (NBS).

The Baby Genes mission is to save lives by providing parents, health care providers and public health departments a more standardized approach to NBS; one that screens for more conditions, is more responsive to current and future needs and provides more actionable information.

Our vision is a standard approach to screening newborns that does not allow a single child to suffer the ill-effects of genetic condition that is both identifiable and treatable from the very beginning. In addition, we want to see a world where the early detection of genetic conditions substantially improves an affected child’s quality of life.

Baby Genes Licensing

 
License Number
Clinical Laboratory Improvement Amendments (CLIA)
06D2084040
California State
COS-00800605
Pennsylvania State
34484
Rhode Island State
LCO00924
Florida State
800027873
Maryland State
2667
New York State
Pending

Baby Genes Tax Information

EIN
46-4079365
NPI
1336527365
DUNS
079232132

See also: